Q3-2021 Ophthalmology Update
The ophthalmology sector continues to see robust transaction volume and has shown no signs of slowing down. Consolidators that are in the latter stages of their respective hold periods, many of which are exploring a sale themselves, have been particularly aggressive from an acquisition standpoint. Provident expects the next wave of investment and consolidation activity to be characterized by secondary deals in which private equity firms exit their positions in their respective platforms to larger private equity firms with a thesis in the space or larger PE-backed MSOs that are in the earlier stages of their hold period.
Provident represented three premier practices through transactions in the quarter that resulted in excellent outcomes and like-minded partnerships between organizations. We continue to track developments in the space and expect deal volume to keep pace with prior quarters in 2021 and beyond.
To print and download the full Ophthalmology Update report, please click below…